Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Henry L.Y. Chan, Scott Fung, Wai Kay Seto, Wan Long Chuang, Chi Yi Chen, Hyung Joon Kim, Aric Josun Hui, Harry L.A. Janssen, Abhijit Chowdhury, Tak Yin Owen Tsang, Rajiv Mehta, Edward Gane, John F. Flaherty, Benedetta Massetto, Anuj Gaggar, Kathryn M. Kitrinos, Lanjia Lin, G. Mani Subramanian, John G. McHutchison, Young Suk LimSubrat K. Acharya, Kosh Agarwal

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial'. Together they form a unique fingerprint.

Medicine & Life Sciences